NCT05000294 2026-02-18
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
University of Florida
Phase 1/2 Suspended
University of Florida
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
UNICANCER
Guangzhou Women and Children's Medical Center
Institut Cancerologie de l'Ouest
Shenzhen Geno-Immune Medical Institute